Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$250M Buy
4,969,664
+318,980
+7% +$16.1M 1.96% 15
2015
Q3
$219M Buy
4,650,684
+556,925
+14% +$29.6M 1.86% 19
2015
Q2
$222M Buy
4,093,759
+381,956
+10% +$21.4M 1.69% 19
2015
Q1
$204M Buy
3,711,803
+90,119
+2% +$5.1M 1.62% 18
2014
Q4
$196M Buy
3,621,684
+3,240,565
+850% +$181M 1.49% 22
2014
Q3
$21.6M Buy
381,119
+154,804
+68% +$8.69M 0.17% 50
2014
Q2
$12.5M Buy
226,315
+160,900
+246% +$8.78M 0.1% 51
2014
Q1
$3.54M Buy
+65,415
New +$3.39M 0.03% 75

Other funds holding MRK

Orbis Holdings's MRK Position: Q4 2015 in Review

Orbis Holdings increased its Merck (MRK) stake by 6.9% in Q4 2015, buying an estimated $16.1M and bringing the position to 4,969,664 shares worth $250M. The position accounts for 1.96% of the portfolio, ranked #15.

Orbis Holdings first reported a position in MRK in Q1 2014 and has held it in 8 quarters since. 1,755 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

  • Orbis Holdings held 4,969,664 shares of Merck worth $250M as of Q4 2015.
  • Orbis Holdings bought 318,980 Merck shares in Q4 2015, an estimated $16.1M.
  • Merck made up 1.96% of Orbis Holdings's portfolio in Q4 2015, its #15 holding.
  • Orbis Holdings first reported a position in Merck in Q1 2014 and has held it in 8 quarters since.
  • 1,755 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.